HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

King Bio Tops List Of Homeopathic Firms FDA Warns In Show Of Enforcement

Executive Summary

FDA warns King Bio, three other homeopathic product marketers. In addition to GMP deficiencies, "we continue to see products labeled as homeopathic that are being marketed without approval for a wide array of diseases and conditions, from chronic pain to cancer,” says FDA Commissioner Gottlieb.

Advertisement

Related Content

OTC Private Labeler RIJ Pharmaceutical Must 'Fully Remediate' Water System
King Bio Recalls Due To Potential Microbial Contamination Approach 500
FDA Reprimands Snake Venom Seller For Pain Claims Amid Opioid Crisis
FDA 'Evolving' Homeopathic Drug Enforcement With Risk-Based Approach
FDA Examination Of Homeopathic Regulation Looks Beyond Safety History

Topics

Advertisement
UsernamePublicRestriction

Register

RS148679

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel